New HIV treatment shot given only twice a year could be a ‘game changer’
Credit score: Pixabay/CC0 Community Area The Foods and Drug Administration has approved Sunlenca, an injectable treatment to suppress HIV for patients who endured drug resistance to other regimens. Industry experts say the new injectable, which functions with considerably less repeated dosing, can be a recreation changer for these whose infections do not answer to other treatment plans. Produced by Gilead Sciences, the drug is the initially of a new class referred to as capsid inhibitors, which perform by blocking the…
